Eloxx Pharmaceuticals ownership disclosure: A group of related investment entities and Daniel Simon report shared beneficial ownership of common stock totaling individual stakes up to 854,973 shares (19.99%) as of filings signed 06/17/2026. The filing states these securities are directly owned by advisory clients of Domicilium Capital Partners LLC.
The schedule lists multiple related holders with reported holdings: BKJLAGG, LLC 602,266 shares (14.1%), and several entities holding between 238,422 and 240,688 shares. The filing notes a 19.99% beneficial ownership limitation and excludes pre-funded warrants in excess of that limit.
Positive
None.
Negative
None.
Insights
Concentrated stake by affiliated investment vehicles reported at the 19.99% threshold.
The filing shows a coordinated position: Domicilium Capital Partners LLC and related entities, plus Daniel Simon, report shared beneficial ownership with the largest single reported stake at 854,973 shares (19.99%). The schedule identifies the ownership as held for advisory clients.
Key dependencies include the disclosed 19.99% beneficial ownership limitation and the exclusion of pre-funded warrants above that cap; subsequent filings could change reported percentages if warrants are exercised or converted.
Shared voting and dispositive power is reported, with no sole voting or sole dispositive authority.
Each named filer reports 0 sole voting and dispositive power and lists substantial shared power counts (e.g., 854,973 shared). This indicates control is exercised collectively or through managed advisory relationships rather than individually.
Watch for amendments if any holder converts warrants or if the group crosses filing thresholds; the joint-filing agreement is attached as Exhibit A.
Key Figures
Largest reported stake:854,973 sharesPercent of class (largest):19.99%BKJLAGG, LLC holdings:602,266 shares+3 more
6 metrics
Largest reported stake854,973 sharesreported by Domicilium Capital Partners LLC and Daniel Simon
Percent of class (largest)19.99%reported beneficial ownership percentage for 854,973 shares
"Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation."
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared dispositive powerfinancial
"Shared Dispositive Power 854,973.00"
pre-funded warrantsfinancial
"Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation."
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
What stake does Domicilium Capital Partners report in ELOX?
Domicilium Capital Partners reports beneficial ownership of 854,973 shares (19.99%). The filing states these shares are directly owned by advisory clients of the firm and are reported with shared voting and dispositive power.
How much does BKJLAGG, LLC hold in Eloxx (ELOX)?
BKJLAGG, LLC holds 602,266 shares, or 14.1%. The schedule lists this as shared voting and dispositive power and is part of a joint filing by related Domicilium entities and Daniel Simon.
Does Daniel Simon personally control the reported shares of ELOX?
Daniel Simon is listed with 854,973 shares (19.99%) with shared voting power. The filing shows no sole voting or sole dispositive power; signatures indicate he signed on behalf of the reporting entities.
Are pre-funded warrants included in the reported ELOX percentages?
No — the filing expressly excludes pre-funded warrants in excess of a 19.99% limit. A comment notes pre-funded warrants held by the reporting persons are excluded above that beneficial ownership cap.
Who receives proceeds or dividends from the reported ELOX shares?
Proceeds and dividend rights are held by advisory clients of Domicilium Capital Partners LLC. The filing states the securities are directly owned by those clients rather than by the reporting entities themselves.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Eloxx Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, $0.01 par value per share
(Title of Class of Securities)
29014R301
(CUSIP Number)
06/05/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
29014R301
1
Names of Reporting Persons
Domicilium Capital Partners LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
854,973.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
854,973.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
854,973.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
19.99 %
12
Type of Reporting Person (See Instructions)
IA, OO
Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.
SCHEDULE 13G
CUSIP Number(s):
29014R301
1
Names of Reporting Persons
Domicilium Real Estate Fund III LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
238,422.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
238,422.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
238,422.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.9 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
29014R301
1
Names of Reporting Persons
Domicilium Real Estate Fund III GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
238,422.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
238,422.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
238,422.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
29014R301
1
Names of Reporting Persons
BKJLAGG, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
602,266.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
602,266.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
602,266.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
14.1 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.
SCHEDULE 13G
CUSIP Number(s):
29014R301
1
Names of Reporting Persons
MSEK Charleston LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
240,688.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
240,688.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
240,688.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.6 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.
SCHEDULE 13G
CUSIP Number(s):
29014R301
1
Names of Reporting Persons
Bold Stroke Investments, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
240,688.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
240,688.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
240,688.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.6 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.
SCHEDULE 13G
CUSIP Number(s):
29014R301
1
Names of Reporting Persons
Daniel Simon
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
854,973.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
854,973.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
854,973.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
19.99 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: Excludes pre-funded warrants held by the Reporting Persons in excess of a 19.99% beneficial ownership limitation.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Eloxx Pharmaceuticals, Inc.
(b)
Address of issuer's principal executive offices:
P.O. Box 274, 10 Court Street, Arlington, MA 02476
Item 2.
(a)
Name of person filing:
Domicilium Capital Partners LLC
Domicilium Real Estate Fund III LP
Domicilium Real Estate Fund III GP LLC
BKJLAGG, LLC
MSEK Charleston LLC
Bold Stroke Investments, LLC
Daniel Simon
(b)
Address or principal business office or, if none, residence:
Domicilium Capital Partners LLC
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092
Domicilium Real Estate Fund III LP
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092
Domicilium Real Estate Fund III GP LLC
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092
BKJLAGG, LLC
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092
MSEK Charleston LLC
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092
Bold Stroke Investments, LLC
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092
Daniel Simon
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092
(c)
Citizenship:
Domicilium Capital Partners LLC - Delaware
Domicilium Real Estate Fund III LP - Delaware
Domicilium Real Estate Fund III GP LLC - Delaware
BKJLAGG, LLC - Delaware
MSEK Charleston LLC - Delaware
Bold Stroke Investments, LLC - Delaware
Daniel Simon - United States
(d)
Title of class of securities:
Common Stock, $0.01 par value per share
(e)
CUSIP Number(s):
29014R301
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Domicilium Capital Partners LLC - 854,973
Domicilium Real Estate Fund III LP - 238,422
Domicilium Real Estate Fund III GP LLC - 238,422
BKJLAGG, LL - 602,266
MSEK Charleston LLC - 240,688
Bold Stroke Investments, LLC - 240,688
Daniel Simon - 854,973
(b)
Percent of class:
Domicilium Capital Partners LLC - 19.99%
Domicilium Real Estate Fund III LP - 5.9%
Domicilium Real Estate Fund III GP LLC - 5.9%
BKJLAGG, LL - 14.1%
MSEK Charleston LLC - 5.6%
Bold Stroke Investments, LLC - 5.6%
Daniel Simon - 19.99%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Domicilium Capital Partners LLC - 0
Domicilium Real Estate Fund III LP - 0
Domicilium Real Estate Fund III GP LLC - 0
BKJLAGG, LLC - 0
MSEK Charleston LLC - 0
Bold Stroke Investments, LLC - 0
Daniel Simon - 0
(ii) Shared power to vote or to direct the vote:
Domicilium Capital Partners LLC - 854,973
Domicilium Real Estate Fund III LP - 238,422
Domicilium Real Estate Fund III GP LLC - 238,422
BKJLAGG, LL - 602,266
MSEK Charleston LLC - 240,688
Bold Stroke Investments, LLC - 240,688
Daniel Simon - 854,973
(iii) Sole power to dispose or to direct the disposition of:
Domicilium Capital Partners LLC - 0
Domicilium Real Estate Fund III LP - 0
Domicilium Real Estate Fund III GP LLC - 0
BKJLAGG, LLC - 0
MSEK Charleston LLC - 0
Bold Stroke Investments, LLC - 0
Daniel Simon - 0
(iv) Shared power to dispose or to direct the disposition of:
Domicilium Capital Partners LLC - 854,973
Domicilium Real Estate Fund III LP - 238,422
Domicilium Real Estate Fund III GP LLC - 238,422
BKJLAGG, LL - 602,266
MSEK Charleston LLC - 240,688
Bold Stroke Investments, LLC - 240,688
Daniel Simon - 854,973
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G are directly owned by advisory clients of Domicilium Capital Partners LLC. None of those advisory clients, except for the advisory clients reported herein, may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value per share.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Domicilium Capital Partners LLC
Signature:
/s/ Daniel Simon
Name/Title:
Daniel Simon, Managing Member of its general partner
